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Abstract
Streptococcus pneumoniae is a commensal human pathogen and the causative agent of various invasive and noninvasive diseases.
Carriage of the pneumococcus in the nasopharynx is thought to be mediated by biofilm formation, an environment where isogenic
populations frequently give rise to morphological colony variants, including small colony variant (SCV) phenotypes. We employed
metabolic characterization and whole-genome sequencing of biofilm-derived S. pneumoniae serotype 22F pneumococcal SCVs to
investigate diversification during biofilm formation. Phenotypic profiling revealed that SCVs exhibit reduced growth rates, reduced
capsule expression, altered metabolic profiles, and increased biofilm formation compared to the ancestral strain. Whole-genome
sequencing of 12 SCVs from independent biofilm experiments revealed that all SCVs studied had mutations within the DNA-directed
RNA polymerase delta subunit (RpoE). Mutations included four large-scale deletions ranging from 51 to 264 bp, one insertion
resulting in a coding frameshift, and seven nonsense single-nucleotide substitutions that result in a truncated gene product. This
work links mutations in the rpoE gene to SCV formation and enhanced biofilm development in S. pneumoniae and therefore may
have important implications for colonization, carriage, and persistence of the organism. Furthermore, recurrent mutation of the
pneumococcal rpoE gene presents an unprecedented level of parallel evolution in pneumococcal biofilm development.
Key words: biofilm, Streptococcus pneumoniae, genomic diversification, parallel evolution.
Introduction
Streptococcus pneumoniae is an encapsulated bacterium that
forms part of the human respiratory biota (Tocheva et al.
2011). Carriage is asymptomatic but known to facilitate trans-
mission of the pathogen and precede pneumococcal infection
(Simell et al. 2012). The resultant diseases can range from
acute otitis media and pneumonia to invasive disease includ-
ing septicemia and meningitis. Although much disease is pre-
ventable by vaccination (Gladstone et al. 2011), it is still a
major cause of morbidity and mortality worldwide (O’Brien
et al. 2009) requiring continuous surveillance.
Carriage of the pneumococcus is thought to be facilitated
by biofilm formation (Marks et al. 2012); biofilms are complex
aggregations of bacteria which adhere to inert or living sur-
faces and are encased in an extracellular polymeric substance
(Costerton et al. 1995). Biofilms are a major contributor to
chronic disease (Hall-Stoodley and Stoodley 2009), and it is
estimated that around 65% of infections are a result of biofilm
GBE
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formation (Potera 1999). Furthermore, pneumococcal biofilm
formation has been directly observed in chronic pneumococ-
cal infections (Hall-Stoodley et al. 2006; Nistico et al. 2011).
Microorganisms have been used extensively to study rapid
evolutionary changes in real time (Buckling et al. 2009); large
populations, short generation times, and relatively simple
genomes, coupled with the advent of next-generation
whole-genome sequencing, allow us to address fundamen-
tally important questions about adaption, mutation, and mor-
phological change within bacterial populations. Growth of
respiratory pathogens within biofilms can result in rapid ge-
netic diversification; colony morphology variants can emerge
that exhibit increased adhesion, dispersal, and/or recalcitrance
to oxidative stress and antibiotics (Boles et al. 2004; Webb
et al. 2004; Allegrucci and Sauer 2008; Mitchell et al. 2010).
Studies of pneumococcal biofilms have shown colony variants
to be both phenotypically and genetically distinct from ances-
tral strains (Waite et al. 2001; Allegrucci and Sauer 2007,
2008; Domenech et al. 2009). Streptococcus pneumoniae is
a highly recombinant organism and prone to mutations that
facilitate long-term persistence in the host (Croucher et al.
2011). This phenomenon of biofilm-mediated genetic diversi-
fication is thought to be a key factor in pneumococcal persis-
tence within the host and is thought to act as a survival
strategy, whereby species with the highest genetic diversity
have the greatest ability to withstand perturbations within the
environment (Boles et al. 2004). The mechanisms by which
bacteria attain such diversity remain unclear and are funda-
mental to understanding how biofilms persist despite contin-
ual antimicrobial therapy and is potentially relevant to future
vaccine design (Jefferies et al. 2011).
Cells growing within a biofilm are subjected to steep
oxygen and pH gradients (Debeer et al. 1994; Sternberg
et al. 1999), resulting in chemical gradients and microenviron-
mental niches within the biofilms (Debeer et al. 1994).
Adaptation to changes in environmental conditions is essential
for survival within the biofilm (Ehrlich et al. 2005). Recently,
spontaneous mucoid variants have been shown to repeatedly
arise in Pseudomonas ﬂuorescens colonies (Kim et al. 2014).
These variants were shown to spatially position themselves on
the surface of the colony to optimize access to oxygen and
nutrients. The authors proposed that the mucoid variants
underwent strong selection in mixed colony experiments
where rapid increase in the mucoid phenotype resulted in
dominance over the wild-type (WT) strain (Kim et al. 2014).
Furthermore, whole-genome sequencing of over 500 mucoid
variants revealed a striking example of parallel evolution at the
rsmE locus (Kim et al. 2014). These data suggest that parallel
evolution can underlie diversification in surface-attached com-
munities of bacteria within biofilms.
In this work, we use a clinical isolate of serotype 22F, which
was chosen as a model serotype because its prevalence in
pneumococcal carriage and disease has increased in both
the United Kingdom and the United States since the
implementation of pneumococcal conjugate vaccines
(Jacobs et al. 2008; Tocheva et al. 2011). We perform both
conventional phenotyping and next-generation sequencing to
characterize the genetic diversity that can arise from biofilm-
derived pneumococci. Mutations that arise in serotype 22F
pneumococcal variants were identified and related to pheno-
typic characteristics. We assess genotype–phenotype relation-
ships and provide insight into genomic factors that are
strongly favored under natural selection in pneumococcal
biofilms.
Results
Three distinct S. pneumoniae colony variants were observed
after 3 days of biofilm growth in microtitre plates: small colony
variants (SCVs) (<0.5 mm), medium colony variants (MCVs)
(0.5–1 mm), and typical colony variants (TCVs) (>1 mm) (fig.
1). Consistent with the ancestral strain, all variants stained
Gram positive, exhibited alpha hemolysis, and remained opto-
chin sensitive. Colony-forming unit (CFU) enumeration of the
biofilm biomass showed that the majority of colonies formed
retained the WT (TCV) morphology, whereas SCVs and MCVs
represented approximately 1% and 4% of the population,
respectively, by day 9 (fig. 1). Quantification of the colony
diameter confirmed that SCVs and MCVs were significantly
distinct from each other and the WT ancestral strain (WT vs.
MCV: T= 13.51, df = 16, P< 0.001; WT vs. SCV: T= 21.38,
df = 16, P< 0.001; MCV vs. SCV: T= 9.73 df = 16, P< 0.001).
In contrast, colonies with the TCV phenotype did not differ
significantly from the WT ancestral strain (T= 0.28, df = 16,
P>0.05) (fig. 2). All variant morphologies had smooth mar-
gins. To determine whether this variation in morphology was a
direct result of biofilm growth and not simply prolonged
growth, planktonic WT cultures were grown for 9 days,
subculturing daily into fresh brain heart infusion (BHI) to main-
tain cell viability. At days 1, 3, 6, and 9, cells were serially
diluted and plated onto blood agar to assess morphology.
Over the 9-day time course, the WT morphology remained
consistent and the presence of small and medium sized colo-
nies was not observed (data not shown).
Biofilm-derived colony variants were assessed for their abil-
ity to form biofilms compared to the ancestral strain. Confocal
laser scanning microscopy (CLSM) revealed that the WT an-
cestor produced relatively flat biofilms with an average thick-
ness of approximately 6 mm and small microcolony towers
with maximum thickness of 12–15 mm (fig. 3A). In contrast,
SCVs produced structured biofilms with an average thickness
of approximately 13 mm and well-defined microcolony towers
with a maximum thickness of 25–35 mm (fig. 3B). The two-
sample t-test revealed that SCV biofilms had significantly
greater biomass (mm3/mm2) (T= 3.26, df = 4, P< 0.05), surface
area (mm2) (T= 3.56, df = 4, P< 0.05), average thickness (mm)
(T= 2.81, df = 4, P<0.05), and maximum thickness (mm)
(T= 5.47, df = 4, P<0.01) compared to the ancestral strain
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FIG. 1.—CFU enumeration of biofilm-derived pneumococcal variants. Cells were harvested from triplicate pneumococcal biofilms from two independent
experiments at time points 1, 3, 6, and 9 days and plated onto CBA to assess for changes in colony morphology. Variants were defined as follows: SCVs
(<0.5 mm), MCVs (0.5–1mm), and TCVs (>1mm). Data represent the mean CFU counts from the two biofilm experiment. Error bars represent standard
error. Images of colonies were taken on CBA under 6 objective on a Leica dissection Stereomicroscope. Scale bar = 1mm.
FIG. 2.—Colony quantification of serotype 22F biofilm-derived colony variants. Diameter values of the three distinct biofilm-derived colony variant
populations harvested from pneumococcal biofilms quantified using ImageJ analysis software. A total of nine colony variants from triplicate biofilms were
measured. Numbers signify mean values.
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(Fig. 4). MCVs produced slightly larger biofilms than WT with
an average thickness of approximately 10 mm and maximum
thickness of 15–20 mm (fig. 3C). TCVs produced biofilm com-
parable with WT; with an average thickness of 8 mm and small
microcolony towers with a maximum thickness of 13–14 mm
(fig. 3D). Biofilms produced by the MCVs and TCVs did not
differ significantly from WT. The percentage of dead cells
within the biofilms was not significantly different between
variants.
Phenotypic profiling using the API Rapid ID 32 Strep assay
confirmed that all SCVs were S. pneumoniae and not contam-
inants. Profiling also revealed that 8 of the 12 SCVs were
unable to metabolize one or all of the following carbon sub-
strates: D-trehalose, pullulan, maltose, and D-saccharose.
Furthermore, SCVs exhibited a reduced growth rate com-
pared to the WT (T= 2.84, df = 37, P< 0.01) (fig. 5) and a
decrease in capsule staining compared to the WT (T= 7.79,
df = 40, P<0.001) (Fig. 6).
To identify mutations responsible for the phenotypic diver-
sity observed in the SCVs, a total of 12 SCVs were harvested
from a 3-, 6-, or 9-day biofilm from two independent biofilm
experiments (five SCVs from experiment 1 and 7 SCVs from
experiment 2) (table 1). The 12 SCVs were sequenced using
next-generation sequencing and compared to the 22F ances-
tral strain. Table 1 lists the confirmed mutations identified in
this work. Notably all sequenced SCVs were shown to contain
independent mutations within the DNA-directed RNA poly-
merase delta subunit (rpoE). With the exception of
FIG. 3.—Biofilm formation of the biofilm-derived colony variants. Three-day-old biofilms of (A) the WT ancestral strain, (B) SCV, (C) MCV, and (D) TCV
were visualized on a Leica TCS SP5 confocal laser scanning microscope using BacLight live/dead stain. Green cells indicate live cells and red cells indicate dead
cells. Z-Scans were performed every 0.3 mm on each field of view. White bars represent 25 mm.
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SCV5D3E1 and SCV7D9E1, these mutations were at different
positions within the gene; SCV5D3E1 and SCV7D9E1 were
isolated from separate biofilms, thus also occurred indepen-
dently. Of the 12 SCVs sequenced, seven SCVs contained
single-nucleotide substitutions resulting in an early stop
codon, one SCV had an insertion mutation resulting in a
coding frameshift, and four SCVs contained large-scale dele-
tions ranging from 51 to 264 bp (table 1). Polymerase chain
reaction (PCR) of the rpoE gene was employed to confirm the
deletions seen in the whole-genome analysis. Sequence anal-
ysis identified short homologous regions flanking the deletions
in three SCVs (SCV9D9E1, SCV1D3E2, and SCV2D6E2), sug-
gesting underlying recombination events; there was no evi-
dence to suggest that the deletion in SCV7D9E2 was a result
of a recombination event. No change in the multilocus se-
quence typing (MLST) profile of the SCVs was observed.
Discussion
Increasing evidence suggests that carriage of the pneumococ-
cus in the nasopharynx of humans is mediated by biofilm
formation (Marks et al. 2012; Blanchette-Cain et al. 2013).
This work used conventional phenotyping and whole-genome
sequencing to characterize the genetic diversity that arises
among biofilm-derived pneumococci. Three distinct colony
morphologies were observed after 3 days of growth, including
a small colony phenotype. This variation in colony morphology
is consistent with previous studies involving other pneumococ-
cal serotypes (Allegrucci and Sauer 2007, 2008) suggesting
that this phenomenon is not an isolated occurrence. Whole-
genome sequencing revealed that all SCVs contained muta-
tions within the DNA-directed RNA polymerase subunit gene
(RpoE), including one insertion, seven substitutions, and four
large-scale deletions. In all cases, these mutations would result
in truncation of the rpoE gene product affecting the low com-
plexity regions of the protein which have been linked to the
specificity of DNA binding. Despite few SCV mutations overall,
these parallel evolutionary events suggest that a strong selec-
tion pressure for rpoE-targeted mutations occurs within
S. pneumoniae biofilms and may be important for biofilm
development.
Of the four deletion events observed in this work, three are
likely to be due to a single intramolecular recombination
FIG. 4.—COMSTAT analysis of biofilm-derived colony variants. Biofilm formation of the biofilm-derived variants quantified using COMSTAT 1 and the
program Matlab (R2012a) (Heydorn et al. 2000) for triplicate 3-day-old biofilms of each variant type, grown in MatTek culture plates under static conditions.
Graph depicts (A) the mean average thickness and maximum thickness, (B) mean biomass, and (C) mean surface area. Error bars represent 95% confidence
intervals.
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event. In all four deletion events, the first 8 bp of the de-
leted sequence commenced with the sequence pattern
GA(C/A)GA(A/C)GA. This sequence pattern may be analogous
to the Chi site seen in Escherichia coli (Prudhomme et al. 2002)
and represent a recognition site for the pneumococcal recom-
binase machinery which in turn results in the deletions seen;
however, this hypothesis remains to be tested. Eight of the 12
sequenced SCVs contained a mutation only in the rpoE gene
with no other additional changes to the genome. With the
exception of SCV5D3E1 and SCV7D9E1, all mutations oc-
curred at different positions in the gene. This observation sup-
ports the hypothesis that mutations in the rpoE gene are
directly linked with the SCV phenotype. The consistent high
frequency of mutations in a single gene, in multiple repli-
cates of independent experiments, is clear evidence of
biofilm-mediated parallel evolutionary events in real time.
Parallel evolution of specific genes has been shown to be clin-
ically relevant in determining the pathogenesis of Burkholderia
dolosa (Lieberman et al. 2011) and P. ﬂuorescens (Kim et al.
2014). Such a phenomenon has also been reported previously
in Pseudomonas aeruginosa (McElroy et al. 2014); however,
this study presents some of the best evidence of parallel evo-
lutionary events in S. pneumoniae.
To date, RpoE has not been studied in S. pneumoniae.
Using Bacillus subtilis as a model organism, RpoE has been
attributed to increasing transcriptional specificity by increasing
binding of RNAP to promoter sequences (Achberger and
Whiteley 1981; Achberger et al. 1982). Additionally, RpoE
has been attributed to increased efficiency of RNA synthesis
and decreased affinity for nucleic acids due to enhanced recy-
cling of RNA (Juang and Helmann 1994; Lopez de Saro et al.
1999). Understanding of the RpoE function is based on gene
deletion studies; rpoE deletion mutants have been shown to
be viable suggesting that RpoE is nonessential (Lopez de Saro
et al. 1999); however, phenotypically rpoE mutant strains have
be shown to display increased lag phase, altered cell
FIG. 5.—Mean growth rate of biofilm-derived SCV phenotype. The growth rate was assessed for SCVs from the exponential growth phase (between 4
and 8 h of growth) from triplicate growth experiments. SCV rate was calculated using pooled data from all 12 sequenced SCVs. A two-sample t-test was
used to compare SCV rate to the WT rate. Numbers signify mean values. Error bars represent 95% confidence intervals.
FIG. 6.—Capsule quantification of the SCV phenotype. Capsule quan-
tification was determined by staining the pneumococcal capsule with
Stains-all solution. The absorbance was measured at optical density
640 nm and subtracted from the negative control. Capsule quantification
was calculated using pooled data from all 12 sequenced SCVs; graph
depicts mean absorbance. Error bars represent 95% confidence intervals.
Graph represents pooled data from all 12 sequenced SCVs.
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morphology (Lopez de Saro et al. 1999), and altered biofilm
architecture (Xue et al. 2010). In all studies to date, disruption
of the rpoE gene has been mediated by deletion or alteration
of the sequence (Lopez de Saro et al. 1995; Xue et al. 2010;
Weiss et al. 2014). Our experiments provide evidence that
mutations affecting the rpoE gene occur spontaneously
during biofilm development. Their recurrence suggests an ad-
vantage in terms of growth and/or survival within biofilms.
Streptococcus pneumoniae is a nutritionally fastidious fac-
ultative anaerobe, but the availability of a glucose source
within the human nasopharynx is thought to be in low con-
centrations (Philips et al. 2003). As biofilm formation is
thought to represent a survival strategy in a nutritionally lim-
ited environment (Domenech et al. 2012), possibly, the reduc-
tion in carbon substrate utilization on the API strip may reflect
selection for strains with reduced metabolic capacity and
growth rate because they are better adapted to survive
under biofilm conditions. Alternatively, there may be selection
against the maintenance of energetically costly pathways not
required under biofilm conditions. Further experimentation
would be required to determine whether either of these hy-
potheses are correct.
We hypothesize that the mutations seen here can benefit
the survival of S. pneumoniae in biofilms by altering gene
expression in favor of colonization rather than virulence. In
Gram-positive bacteria, RpoE has been shown to be important
for rapid changes in gene expression to adapt to changing
environmental conditions (Xue et al. 2010; Xue et al. 2011;
Xue et al. 2012; Rabatinova et al. 2013). The reduction in
growth rate seen in SCVs in this study is consistent with
RpoE studies in B. subtilis (Lopez de Saro et al. 1999). The
slower growth that we observed may be beneficial to a
subpopulation of SCVs in the biofilm because it may allow
bacteria to avoid direct competition between neighboring
cells under conditions of limited nutrient availability. A
number of studies have shown biofilm variants to have re-
duced virulence (Sanchez et al. 2011), which may similarly
reflect a change in gene expression that promotes survival
within biofilms. Interestingly, RpoE has been shown to be
upregulated in response to quorum sensing molecule autoin-
ducer-2 in Streptococcus mutans (Sztajer et al. 2008).
Of note, additional point mutations were also observed in
choline binding protein J, the streptococcal histidine triad pro-
tein, and the iron compound ABC uptake transporter perme-
ase protein (PiuB). This observation is relevant as mutations
within cell surface proteins may inform future protein-based
pneumococcal vaccine studies. Protein-based pneumococcal
vaccine design should be cautious not to target cell surface
proteins, which have a tendency to mutate, as this may result
in vaccine-escape. It is interesting to note that we observed no
mutations within the capsule genes of the biofilm-derived var-
iants. This differs from previous studies that implicated a 7 kb
deletion in the cps3DSU operon in the formation of SCV var-
iants in serotype 3 (Allegrucci and Sauer 2007). Whether bio-
film-mediated mutations are a result of natural selection
acting on random mutational events or a process of targeted
or adaptive mutation remains to be determined (Banas et al.
2007). In this work, the lack of SCV phenotypes in the plank-
tonic population and the variety of rpoE mutations seen would
suggest a strong selection pressure for rpoE-targeted
Table 1
SCV Mutations Identiﬁed Using Next-Generation Sequencing
Variant Reference Position WT Variant Gene Description Effect Coverage Percentage Conﬁdence
SCV1D3E1 423010 G T DNA-directed RNA polymerase delta subunit E173Stop 49 98
SCV5D3E1 422977 G T DNA-directed RNA polymerase delta subunit E163Stop 69 100
SCV3D9E1 328131 A C Choline binding protein J Q118P 30 96.7
SCV3D9E1 422921 C A DNA-directed RNA polymerase delta subunit S144Stop 44 100
SCV3D9E1 908199 T G Hydrolase, putative L26V 27 96.4
SCV7D9E1 422977 G T DNA-directed RNA polymerase delta subunit E163Stop 243 100
SCV9D9E1 422795–423059 A — DNA-directed RNA polymerase delta subunit Deletion NA NA
SCV9D9E1 1620361 C A Iron compound ABC uptake transporter
permease protein PiuB
A278D 47 97.4
SCV1D3E2 422765–422894 A — DNA-directed RNA polymerase delta subunit Deletion NA NA
SCV2D6E2 422799–423063 G — DNA-directed RNA polymerase delta subunit Deletion NA NA
SCV4D6E2 422947 G T DNA-directed RNA polymerase delta subunit E153Stop 197 99.5
SCV4D6E2 591574 G T Beta-galactosidase A146S 129 98.5
SCV4D6E2 1396435 C T Glycine/D-amino acid oxidases family R412H 137 100
SCV6D6E2 423020 — G DNA-directed RNA polymerase delta subunit Insertion 92 93.9
SCV5D9E2 423028 G T DNA-directed RNA polymerase delta subunit E180Stop 146 100
SCV6D9E2 422962 G T DNA-directed RNA polymerase delta subunit E158Stop 122 99.2
SCV7D9E2 423028–423090 G — DNA-directed RNA polymerase delta subunit Deletion NA NA
SCV7D9E2 1035274 G A Streptococcal histidine triad protein Q111Stop 106 100
Note.—D3,day 3 bioﬁlm; D6,day 6 Bioﬁlm; D9,day 9 bioﬁlm, E1,experiment 1; E2,experiment 2.
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mutations occurs within S. pneumoniae biofilms and may be
important for biofilm development.
This work has shown that diversification under biofilm con-
ditions resulted in the emergence of SCVs with parallel muta-
tions within the rpoE gene. Further work is investigating the
transcriptional and translational effect of rpoE mutation on
biofilm development and its clinical significance, as well as
comparisons of genomic diversification between disease and
carriage isolates of S. pneumoniae 22F. This study presents an
unprecedented level of biofilm-mediated parallel evolution in
S. pneumoniae and suggests a strong positive selection for
mutations in rpoE, which may identify rpoE as an important
gene for biofilm formation, carriage, and pathogenicity of the
pneumococcus.
Materials and Methods
Bacterial Strains
The clinical isolate (ID: sp_3016) of S. pneumoniae 22F (ST433)
was obtained from the third year (October 2009–March 2010)
of an on-going nasopharyngeal carriage study in children
aged 4 years and under at University Hospital Southampton,
UK. Isolates were stored at80 C in glycerol stock consisting
of 50% BHI broth (Oxoid) and 50% glycerol (Sigma). Capsular
serotyping of the reference isolate was performed using ge-
nomic DNA and multiplex PCR (Pai et al. 2006) and MLST was
performed using Qiagen Genomic Services and ST’s assigned
using the MLST website (www.mlst.net, last accessed 2012)
prior to biofilm experimentation.
Growth Curves
Isolates were grown on Columbia blood agar (CBA) plates
(Oxoid) overnight, colonies were used to inoculate 10 ml of
BHI broth, and subsequently incubated at 37 C with 5% CO2
for 10 h. The optical density (OD600) was measured every hour
and 100 ml of culture taken every 2 h to perform viable counts.
Growth curves for each strain were performed in triplicate on
separate days.
Biofilm Culture and Colony Variation
1  108 CFU/ml was inoculated into MatTek culture plates
(MatTek Corporation Ashland, MA) or six-well micotitre
plates (Nunc) were inoculated using 1108 CFU/ml as
described previously (Hall-Stoodley et al. 2008). Triplicate bio-
films were grown under static conditions at 37 C with 5%
CO2 for 1, 3, 6, and 9 days in two independent experiments.
Half of the culture media was removed daily and replaced with
equal quantities of fresh 1:5 BHI prewarmed to 37 C. At each
time point, biofilms were washed twice with fresh prewarmed
1:5 BHI, and the biomass was harvested using a cell scraper,
vortexed, diluted to 10 6 and 100 ml was plated onto CBA
(Oxoid) in triplicate to assess changes in colony morphology
compared to the inoculum. The growth rate was assessed for
SCVs using the equation m= ((log10 N – log10 N0) 2.303)/(t 
t0) and CFU data from the exponential growth phase (between
4 and 8h of growth) from triplicate growth experiments.
Assessment of Colony Morphology
Colony morphology was assessed based on size and regularity
of the colony surface. Variants were defined as follows; SCVs
(<0.5 mm), MCVs (0.5–1 mm), and TCVs (>1 mm). Colonies
were visualized using a Leica MZ 16F stereomicroscope, and
images were taken using a Leica digital camera with micro-
scope and a 5 mm graticule scale. Colony diameters were
quantified using the ImageJ analysis software (http://rsbweb.
nih.gov/ij/, last accessed July 2012). A total of nine colony
variants from triplicate biofilms were measured. Per experi-
ment, up to 12 phenotypic variants of each morphology
type were selected, per time point, from the triplicate biofilms.
Variants were subcultured and stored at 80 C in glycerol
stock for future phenotypic and genetic analysis. Additional
phenotypic characterization and whole-genome sequencing
were performed on 12 SCVs harvested from two independent
experiments. Five SCVs were characterized from experiment 1
(33-day-old biofilms and 2 9-day-old biofilms) and seven
SCVs from experiment 2 (13-day-old biofilms, 3 6-day-
old biofilms and 39-day-old biofilms).
Visualization of the Biofilm
Biofilms were imaged using CLSM and BacLight live/dead stain
(Life Sciences). Triplicate biofilms of each variant type were
cultured in MatTek culture plates (MatTek Corp., Ashland,
OR) under static biofilm conditions for 3 days, washed twice
with fresh warmed 1:5 strength BHI, and then stained accord-
ing to the manufacturer’s instructions. All images were taken
using a 63 objective on a Leica TCS SP5 confocal laser scan-
ning microscope on a Leica DMI6000 inverted microscope
frame. Five fields of view were taken per triplicate biofilm.
Z-Scans were performed every 0.3 mm on each field of
view. Biofilm formation was quantified using COMSTAT 1
and the program Matlab (R2012a) (Heydorn et al. 2000) to
determine the average thickness and maximum thickness,
total biomass, and surface area of the WT and SCV biofilms.
API Rapid ID 32 Strep Assay
API Rapid ID 32 Strep assay (bioMe´rieux) was performed ac-
cording to the manufacturer’s instructions.
Capsule Quantification
Quantification of the capsule was adapted and performed
according to Hammerschidt et al. (2005) and Rukke et al.
(2012). SCVs were grown on CBA plates (Oxoid) overnight
at 37 C and 5% CO2. The growth was transferred to 10 ml of
BHI and cultured to an OD equating to approximately 108
CFU/ml (OD600 ~ 0.3–4). Cultures (5 ml) were centrifuged
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(2500  g at 4 C for 10 min) to pellet the cells. The super-
natant was discarded, the pellet washed twice in 0.5 ml phos-
phate-buffered saline, and then resuspended into 5 ml of
sterile distilled water. Resuspended cells (250 ml) were trans-
ferred to a sterile microcentrifuge tube and 1 ml of stain-all
solution (20 mg Stains-all [Sigma-Aldrich], 60 ml glacial acetic
acid in 100 ml of 50% formamide) added. Absorbance was
measured at 640 nm and subtracted from the negative control
(250 ml of sterile distilled water stained with 1 ml of Stains-all).
Capsule quantification was measured in triplicate, with each
measurement performed on separate days.
Genomic DNA Extraction
Genomic DNA for whole-genome sequencing was extracted
from 10 ml cultures of BHI containing approximately 109 CFU/
ml using Qiagen Genomic tip 100/G in accordance with the
manufacturer’s instruction for Gram-positive bacteria.
Genomic DNA for PCR was extracted using the QIAamp
DNA mini kit (QIAGEN) according to the manufacturer’s in-
structions with minor modifications. Frozen stocks of each iso-
late were streaked onto CBA (Oxoid) and incubated at 37 C
in 5% CO2. Colony growth was transferred using a sterile
swab to 200 ml of lysis buffer (10 mM Tris pH8, 100 mM eth-
ylenediaminetetraacetic acid pH8, 0.5% w/v sodium dodecyl
sulphate) and incubated at 37 C for 1 h. Proteinase K (20 ml)
was added and samples were incubated at 56 C for 1 h. The
following steps were performed as described in the Qiagen
QIAamp mini kit protocol.
Whole-Genome Sequencing
Biofilm-derived variants and the ancestral WT 22F strain under-
went shot gun paired end whole-genome sequencing using
the Roche GS Junior and/or the Illumina MiSeq. The ancestral
22F strain was sequenced both on the Roche GS junior 454
sequencer and on the Illumina MiSeq using the 150 base, pair-
end protocol. The 12 SCV samples were sequenced on the
Illumina MiSeq (2  150 or 2  250bp). For Roche GS junior
454 paired-end sequencing, genomic DNA was sheared and
GS Titanium Library Paired End Adaptors were added to the
fragments, emPCR was performed using the Roche GS Junior
Titanium emPCR Kit (Lib L). Samples were loaded onto the
Roche GS Junior PicoTiterPlate according to the manufacturer’s
instructions and the Roche GS Junior Titanium Sequencing Kit.
For Illumina MiSeq sequencing, all samples were sheared and
libraries were prepared using the Nextera library prep kit,
Illumina MiSeq reagent cartridge, and sequencing reagents
were used according to the manufacturer’s instructions.
Paired-end sequencing of the WT strain acted as the template
for comparing the variants. Illumina sequence data were as-
sembled de novo using Velvet (Zerbino 2010) and the Velvet
optimizer script generating assemblies with an average cover-
age of 62. Assemblies were assessed for quality using the
assemblathon script, and satisfactory n50 scores were
generated (mean=40,945bp) (Earl et al. 2011). For the ances-
tral 22F strain, Roche GS junior 454 sequence data were as-
sembled de novo using Newbler GSassembler with Illumina
sequence data to generate a more comprehensive reference
sequence. The resultant assembly of the ancestral strain had an
86 depth of coverage. The de novo assembled scaffolds of
the ancestral strain were aligned against strain D39 reference in
Mauve (Darling et al. 2010) to arrange the scaffold. All gaps
were removed to create a pseudoreference from which all an-
notations were based. Annotation of the ancestral strain de
novo assembly was achieved using RAST, the online annotation
service (Overbeek et al. 2014). Sequence data are available
from the NCBI Sequence Read Archive (http://www.ncbi.nlm.
nih.gov/sra/, last accessed March 2016) under the accession
number: SRP071227.
MLST of Biofilm-Derived Variants
All sequences were assembled de novo as described above;
the assembled contigs were uploaded to the Centre for
Genomic Epidemiology online service (Larsen et al. 2012) to
assess for changes in MLST from the ancestral strain ST433.
Mutation Analysis
Point mutations were identified by mapping variant genome
sequences against the annotated ancestral strain reference.
Illumina fastq reads were mapped against the ancestral 22F
strain sequence using STAMPY (Lunter and Goodson 2011).
The output sequence alignment mapping files were converted
to binary alignment mapping files using SAMtools and variant
discovery was performed using mpileup, bcftools, and gatk
annotator (Li et al. 2009; McKenna et al. 2010) to generate
variant call files (.vcf), which contained the list of nucleotide
variants, their position, and quality metrics. Variants were fil-
tered based on quality score (q value) and those with q
values<20 were rejected. Alternatively, variant call files (.vcf)
were generated using SNPtree1.1 (Leekitcharoenphon et al.
2012). Each mutation was manually curated by mapping the
Illumina fastq files against the WT reference to generate bam
files (.bam) and indexed bam files (.bai) using SAMtools. Bam
files were subsequently visualized using Integrative Genomics
Viewer (Robinson et al. 2011; Thorvaldsdottir et al. 2013) to
determine coverage and percentage confidence for each vari-
ant. Furthermore, the percentage confidence of each mutation
was calculated as the coverage of the identified variant base call
divided by the total base call coverage at the variant position.
Mutations underwent rigorous selection criteria to avoid mis-
calling. Only variant positions that were present in both the
mapping data and de novo assemblies (>20 coverage and
a percentage confidence>90%) were classed as confidently
identified mutations. Functional effects of the mutations were
postulated using the ExPASy research portal (Artimo et al.
2012) and the EMBL SMART database (Schultz et al. 1998;
Letunic et al. 2012).
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PCR of rpoE
To confirm the validity of the rpoE deletions in the SCVs, DNA
from each SCV underwent PCR for the rpoE gene. The rpoE
gene is 588 bp in length and primers were designed to amplify
an amplicon of 609 bp, encompassing the full rpoE gene.
Forward primer 5’-GAGGAGAAACGCTTTGGAATTAGAAG-3’
and reverse primer 5’-GCTAACTCTTATTCCTCGCTGGTTTC-3’
were designed. PCR program consisted of three stages: stage
1: 94 C for 5 min; stage 2: 30 cycles of 94 C for 30 s 50 C
for 30 s 72 C for 30 s; stage 3: 72 C for 10 min; and stage 4:
pause at 4 C. PCR products were run out on a 1% agarose
gel containing GelRed for 45 min at 90 V and visualized under
ultraviolet light. Bioline HyperLadder II was used to assess the
size of the bands.
Statistical Analysis
All statistical analysis was performed on Minitab 16.2
Statistical Software (www.minitab.com, last accessed
November 2015). Normality of the data was determined
using the Anderson–Darling test and equality of variance
was determined using the F test. Normality and equal variance
were achieved after square root transformation of the growth
rate and capsule staining data. Prior to analysis, data from all
12 sequenced SCVs were pooled and the two-sample t-test
was used to determine a significant difference between the
SCV phenotype and the WT 22F strain.
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